Citation Tools
PDFTherapeutics
Randomised controlled trial
In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding